Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 10 | uM | 8 | 1250.00 | 622.75 | 846.00 | 1673.00 | 0.5057 | 0.2397 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1913.00 | 1673.00 | 1.1435 | 1.1972 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 1250.00 | 622.75 | 1940.00 | 1673.00 | 1.1596 | 1.2189 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1778.00 | 1673.00 | 1.0628 | 1.0872 |
| BT-20 | Lapatinib | 1 | uM | 8 | 1250.00 | 622.75 | 1861.00 | 1673.00 | 1.1124 | 1.1551 |
| BT-20 | Linsitinib | 10 | uM | 8 | 1250.00 | 622.75 | 1849.00 | 1673.00 | 1.1052 | 1.1454 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1788.00 | 1673.00 | 1.0687 | 1.0955 |
| BT-20 | Erlotinib | 10 | uM | 8 | 1250.00 | 622.75 | 1680.00 | 1673.00 | 1.0042 | 1.0059 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 1703.00 | 1673.00 | 1.0179 | 1.0251 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 2006.00 | 1673.00 | 1.1990 | 1.2716 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 1250.00 | 622.75 | 1047.00 | 1673.00 | 0.6258 | 0.4397 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1644.00 | 1673.00 | 0.9827 | 0.9756 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 1250.00 | 622.75 | 1857.00 | 1673.00 | 1.1100 | 1.1519 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1614.00 | 1673.00 | 0.9647 | 0.9503 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 1250.00 | 622.75 | 1835.00 | 1673.00 | 1.0968 | 1.1340 |
| BT-20 | Linsitinib | 1 | uM | 8 | 1250.00 | 622.75 | 1755.00 | 1673.00 | 1.0490 | 1.0683 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1567.00 | 1673.00 | 0.9366 | 0.9103 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1289.00 | 1673.00 | 0.7705 | 0.6657 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1248.00 | 1673.00 | 0.7460 | 0.6284 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1565.00 | 1673.00 | 0.9355 | 0.9085 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 1250.00 | 622.75 | 862.00 | 1673.00 | 0.5152 | 0.2561 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1447.00 | 1673.00 | 0.8649 | 0.8064 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1822.00 | 1673.00 | 1.0891 | 1.1233 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 2044.00 | 1673.00 | 1.2218 | 1.3017 |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1836.00 | 1673.00 | 1.0974 | 1.1348 |